Concepedia

Rolf W. Sparidans

RW

128

Publications

4.6K

Citations

38

H-Index

1988

Active since

Affiliations

Utrecht University(Current)

The Netherlands Cancer Institute

Slotervaartziekenhuis

Oncode Institute

Pharmo Institute

Rolf W. Sparidans is an author at Utrecht University specializing in medicine, pharmacology, and bioanalysis.

ORCID

Top concepts

Publications per year

1988–2023

128

Publications

128

Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export

Raymond Evers, Marcel de Haas, Rolf W. Sparidans et al. · British Journal of Cancer · 2000 · 227 citations · Full text

Breast Cancer Resistance Protein and P-glycoprotein Limit Sorafenib Brain Accumulation

Jurjen S. Lagas, Robert A.B. van Waterschoot, Rolf W. Sparidans et al. · Molecular Cancer Therapeutics · 2010 · 180 citations

Collagen degradation and neutrophilic infiltration: a vicious circle in inflammatory bowel disease

Pim J. Koelink, Saskia A. Overbeek, Saskia Braber et al. · Gut · 2013 · 160 citations · Full text

Increased oral availability and brain accumulation of the ALK inhibitor crizotinib by coadministration of the P‐glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) inhibitor elacridar

Seng Chuan Tang, Luan N. Nguyen, Rolf W. Sparidans et al. · International Journal of Cancer · 2013 · 144 citations · Full text

Oral Availability and Brain Penetration of the B-RAF <sup>V600E</sup> Inhibitor Vemurafenib Can Be Enhanced by the P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) Inhibitor Elacridar

Selvi Durmuş, Rolf W. Sparidans, Els Wagenaar et al. · Molecular Pharmaceutics · 2012 · 124 citations

Rows per page

1–5 of 128